EP Patent

EP4089091A1 — Biphenyl fluorine double bond derivative, preparation method therefor, and pharmaceutical application thereof

Assigned to Abbisko Therapeutics Co Ltd · Expires 2022-11-16 · 4y expired

What this patent protects

A biphenyl fluorine double bond derivative having a structure as represented by formula (I), a preparation method therefor, and a pharmaceutical application thereof. The biphenyl fluorine double bond derivative having the structure as represented by formula (I) can be widely appl…

USPTO Abstract

A biphenyl fluorine double bond derivative having a structure as represented by formula (I), a preparation method therefor, and a pharmaceutical application thereof. The biphenyl fluorine double bond derivative having the structure as represented by formula (I) can be widely applied in the preparation of medicaments for preventing and/or treating cancers or tumors, immune-related diseases and disorders, communicable diseases, infectious diseases or metabolic diseases mediated by PD-1/PD-L1 signal pathways, and is expected to be developed into a new generation of PD-1/PD-L1 inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
EP4089091A1
Jurisdiction
EP
Classification
—
Expires
2022-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Abbisko Therapeutics Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.